469 related articles for article (PubMed ID: 16813270)
1. [Drugs used in cardiovascular diseases and cytokines].
Andrzejczak D; Górska D
Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
[TBL] [Abstract][Full Text] [Related]
2. [Current problems of pharmacotherapy--heart failure].
Bertel O; Kaufmann U
Ther Umsch; 1990 Aug; 47(8):686-92. PubMed ID: 1977205
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of heart failure and preserved systolic function].
Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
[No Abstract] [Full Text] [Related]
4. [Progress in cardiovascular pharmacology].
Zhu JR
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Dec; 21(6):358-60. PubMed ID: 7913889
[No Abstract] [Full Text] [Related]
5. Cardiovascular drug therapy in the elderly.
Aronow WS; Frishman WH; Cheng-Lai A
Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
[TBL] [Abstract][Full Text] [Related]
6. [Left ventricular diastolic dysfunction in ischemic heart disease. Effects of drug therapy].
Witkowska M
Kardiol Pol; 1992 Dec; 37(12):399-403. PubMed ID: 1363437
[No Abstract] [Full Text] [Related]
7. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.
Jochmann N; Stangl K; Garbe E; Baumann G; Stangl V
Eur Heart J; 2005 Aug; 26(16):1585-95. PubMed ID: 15996977
[TBL] [Abstract][Full Text] [Related]
8. Calcium-channel antagonists in cardiovascular disease.
Holdright DR
Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
Avezum A; Pais P; Flather MD; Anand S; Yusuf S
Indian Heart J; 1995; 47(2):95-105. PubMed ID: 7590849
[No Abstract] [Full Text] [Related]
10. [Progress in medical treatment of heart failure].
López Mora E
Arch Cardiol Mex; 2001; 71 Suppl 1():S95-101. PubMed ID: 11565355
[TBL] [Abstract][Full Text] [Related]
11. Application of calcium channel blockers in the treatment of cardiovascular diseases.
Herman ZS
Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650
[TBL] [Abstract][Full Text] [Related]
12. Cardiac medication in the perioperative period.
Wallner T; Preis C; Mayer N
Acta Anaesthesiol Scand Suppl; 1997; 111():22-8. PubMed ID: 9420942
[No Abstract] [Full Text] [Related]
13. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein (CRP)-lowering agents.
Prasad K
Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
[TBL] [Abstract][Full Text] [Related]
16. Heart failure.
McKelvie R
Clin Evid; 2006 Jun; (15):118-39. PubMed ID: 16973007
[No Abstract] [Full Text] [Related]
17. Heart failure.
McKelvie R
Clin Evid; 2003 Jun; (9):95-118. PubMed ID: 12967355
[No Abstract] [Full Text] [Related]
18. [Present trends and controversies in the use of beta-blockers in cardiovascular diseases].
Spoladore R; Fragasso G; Montanaro C; Maranta F; Torlasco C; Gerosa S; Margonato A
Recenti Prog Med; 2010 Nov; 101(11):429-41. PubMed ID: 21197763
[TBL] [Abstract][Full Text] [Related]
19. [Sex differences and cardiovascular drugs].
Løchen ML; Kvan E
Tidsskr Nor Laegeforen; 2010 Feb; 130(4):382-4. PubMed ID: 20220863
[TBL] [Abstract][Full Text] [Related]
20. Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients.
Ranchord AM; Harding SA; Pidgeon G
Intern Med J; 2008 May; 38(5):361-4. PubMed ID: 18402563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
